|
End-of-day quote
Korea S.E.
20/11/2026
|
5-day change | 1st Jan Change | ||
| 3,655.00 KRW | -2.66% |
|
-14.20% | -45.28% |
| 13/11 | MedPacto, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| 21/09 | MedPacto, Inc.(KOSDAQ:A235980) dropped from S&P Global BMI Index | CI |
Company Valuation: MedPacto, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 23,93,411 | 12,01,906 | 4,69,045 | 2,43,124 | 1,52,010 | 2,28,958 |
| Change | - | -49.78% | -60.97% | -48.17% | -37.48% | 50.62% |
| Enterprise Value (EV) 1 | 23,48,548 | 10,80,523 | 4,35,468 | 1,72,948 | 98,472 | 1,89,985 |
| Change | - | -53.99% | -59.7% | -60.28% | -43.06% | 92.93% |
| P/E | -94.2x | -70.4x | -13x | -4.35x | -7.42x | -17.9x |
| PBR | 43x | 27.6x | 14.5x | 3.43x | 2.63x | 4.98x |
| PEG | - | 2.1x | -0x | 1.85x | 0.1x | 0.5x |
| Capitalization / Revenue | - | - | - | - | - | 5,87,30,052x |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | -89.1x | -39x | -12.3x | -6.42x | -4.86x | -14.7x |
| EV / EBIT | -84.5x | -36.7x | -11.7x | -6.02x | -4.52x | -13.5x |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1,249 | -832.3 | -1,705 | -1,665 | -598 | -374 |
| Distribution rate | - | - | - | - | - | - |
| Net sales | - | - | - | - | - | 3,898 |
| EBITDA 1 | -26,363 | -27,736 | -35,380 | -26,919 | -20,265 | -12,888 |
| EBIT 1 | -27,800 | -29,459 | -37,246 | -28,752 | -21,807 | -14,044 |
| Net income 1 | -25,352 | -17,040 | -35,753 | -35,325 | -20,140 | -12,811 |
| Net Debt 1 | -44,863 | -1,21,383 | -33,577 | -70,177 | -53,538 | -38,973 |
| Reference price 2 | 1,17,700.00 | 58,600.00 | 22,250.00 | 7,240.00 | 4,435.00 | 6,680.00 |
| Nbr of stocks (in thousands) | 20,335 | 20,510 | 21,081 | 33,581 | 34,275 | 34,275 |
| Announcement Date | 14/03/22 | 14/03/22 | 13/03/23 | 20/03/24 | 20/03/25 | 18/03/26 |
1KRW in Million2KRW
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 9.34Cr | ||
| 16.7x | 6.32x | 12.11x | 1.79% | 6.37TCr | ||
| 31.66x | 8.45x | 27.93x | 0.07% | 5.86TCr | ||
| 37.7x | 6.72x | 20.09x | 0.86% | 5.42TCr | ||
| 40.47x | 5.8x | 27.69x | -.--% | 4.47TCr | ||
| 32.08x | 3.11x | 13.42x | -.--% | 4.05TCr | ||
| 36.47x | 8.88x | 23.19x | 0.36% | 3.63TCr | ||
| -19.34x | 51.61x | -20.92x | -.--% | 3.49TCr | ||
| 41.15x | 7.94x | 26.62x | -.--% | 3.23TCr | ||
| -87.55x | 16.38x | -94.1x | -.--% | 3.1TCr | ||
| Average | 14.37x | 12.80x | 4.00x | 0.34% | 4TCr | |
| Weighted average by Cap. | 18.51x | 11.45x | 8.40x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- A235980 Stock
- Valuation MedPacto, Inc.
Select your edition
All financial news and data tailored to specific country editions
















